Search

Memorial Sloan Kettering Cancer Center (MSK) is partnering with DigitasLBi and Phase2 to help expand MSK's digital reach.

… Thursday, June 19, 2014 Memorial Sloan Kettering Cancer Center (MSK) today announced the appointment of DigitasLBi as its digital agency of record and Phase2 as its Drupal technology partner. Memorial Sloan Kettering’s digital reach is significant, and the institution is viewed as one of the country’

Memorial Sloan Kettering and Quest Diagnostics announced a joint collaboration that will utilize MSK’s clinical and research insights into gene mutations associated with solid tumors.

… Sunday, June 1, 2014 Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance research Memorial Sloan Kettering Cancer Center, the world’s oldest and largest private cancer center, and Quest Diagnostics (NYSE: DGX), the world’s leading

Learn how a new imaging approach lights up nerves so they can be avoided during prostate cancer surgery.

… Wednesday, July 9, 2025 Men having  prostate cancer  surgery often fear  side effects  that can result from the procedure. Removing the tumor risks damage to surrounding nerves, resulting in erectile dysfunction and incontinence. Now a new way to light up nerves during the operation may help surgeons

Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status. Their research was published today online in JAMA Oncology.

… Thursday, July 18, 2019 Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS ) can convert to high-risk MGUS and progress

AACR Project GENIE steering committee head and Chair of MSK’s Human Oncology and Pathogenesis Program, Dr. Charles Sawyers, discusses how the first batch of genomic sequencing data fulfills an unmet need in oncology.

… Wednesday, February 15, 2017 In early 2017 a global collaboration of eight cancer centers led by Memorial Sloan Kettering and coordinated by the American Association for Cancer Research (AACR), released its first batch of data: genomic sequencing information on tumors from over 19,000 cancer patients

Scientists have learned that a drug activates a form of highly inflammatory programmed cell death called pyroptosis — a discovery that sheds light on immune function.

… Monday, December 19, 2016 Summary A drug called Val-boroPro triggers an immune response against cancer in mice, but until now, researchers didn’t know the mechanism. The laboratory of Daniel Bachovchin at MSK discovered that Val-boroPro blocks two proteins, DPP8 and DPP9, causing a form of inflammatory

The risk of breast cancer increases as you age. MSK has breast cancer experts with special training and experience treating older patients.

… Thursday, September 7, 2023 When Vivian Moore was diagnosed with breast cancer at age 80, she worried how well she would tolerate the treatments. Living a full life, she was active in her church and busy with sewing, knitting, and sketching. She wanted to continue doing the things she loves. While some

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that it is ranked among one of the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.

… Wednesday, November 15, 2023 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that it is ranked among one of the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the  annual list  of Highly Cited Researchers published by the 

Learn about seven nursing staff members were honored with a Robbins Family Award for Nursing Excellence.

… Thursday, October 1, 2020 Andrea Smith Excellence in Nursing Leadership — Andrea Smith (Nurse Leader, Outpatient Nursing Services, Evelyn H. Lauder Breast Center) Leon Chen Excellence in Advanced Nursing Practice — Leon Chen (Nurse Practitioner, Critical Care, Intensive Care Unit) Jessica Agostini Excellence

Memorial Sloan Kettering Cancer Center has announced the appointment of medical oncologist Paul Sabbatini to the new position of Deputy Physician-in-Chief for Clinical Research.

… Thursday, January 17, 2013 Memorial Sloan Kettering Cancer Center has announced the appointment of medical oncologist Paul Sabbatini to the new position of Deputy Physician-in-Chief for Clinical Research. In this role, Dr. Sabbatini will streamline and accelerate the clinical research process while ensuring